CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 75 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $522,000 | +3.4% | 982,916 | +19.9% | 0.00% | – |
Q4 2021 | $505,000 | -27.0% | 819,506 | +20.7% | 0.00% | -100.0% |
Q3 2021 | $692,000 | -47.1% | 678,716 | -5.1% | 0.00% | 0.0% |
Q2 2021 | $1,309,000 | +22.7% | 715,435 | +32.2% | 0.00% | 0.0% |
Q1 2021 | $1,067,000 | -58.9% | 541,302 | -73.9% | 0.00% | -50.0% |
Q4 2020 | $2,593,000 | -37.8% | 2,074,154 | -10.4% | 0.00% | -50.0% |
Q3 2020 | $4,168,000 | -76.1% | 2,315,488 | +11.4% | 0.00% | -81.0% |
Q2 2020 | $17,437,000 | +165.9% | 2,078,342 | +66.1% | 0.02% | +110.0% |
Q1 2020 | $6,557,000 | +77.9% | 1,251,270 | +85.3% | 0.01% | +150.0% |
Q4 2019 | $3,686,000 | +2.4% | 675,153 | -8.7% | 0.00% | 0.0% |
Q3 2019 | $3,600,000 | -45.4% | 739,110 | -22.3% | 0.00% | -50.0% |
Q2 2019 | $6,592,000 | -19.2% | 951,134 | -19.0% | 0.01% | -27.3% |
Q1 2019 | $8,163,000 | +161.2% | 1,174,551 | +119.5% | 0.01% | +175.0% |
Q4 2018 | $3,125,000 | +3620.2% | 535,121 | +4409.7% | 0.00% | – |
Q4 2017 | $84,000 | -6.7% | 11,866 | -6.0% | 0.00% | – |
Q3 2017 | $90,000 | – | 12,626 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 5,045,870 | $6,307,000 | 4.30% |
ETF MANAGERS GROUP, LLC | 8,103,641 | $10,130,000 | 0.22% |
AdvisorShares Investments LLC | 271,873 | $340,000 | 0.08% |
Platform Technology Partners | 60,000 | $75,000 | 0.04% |
PINNACLE ASSOCIATES LTD | 942,079 | $1,178,000 | 0.02% |
HRT FINANCIAL LP | 883,510 | $1,104,000 | 0.02% |
Virtu Financial LLC | 153,908 | $192,000 | 0.02% |
Tekla Capital Management LLC | 413,481 | $517,000 | 0.02% |
Aries Wealth Management | 23,400 | $33,000 | 0.02% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 56,932 | $71,000 | 0.02% |